Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer’s drug
Leqembi is the first Alzheimer’s antibody treatment to receive full FDA approval.
Leqembi is the first Alzheimer’s antibody treatment to receive full FDA approval.
